140 related articles for article (PubMed ID: 12419319)
21. Internalization-dependent regulation of HT29 cell proliferation by neurotensin.
Navarro V; Martin S; Mazella J
Peptides; 2006 Oct; 27(10):2502-7. PubMed ID: 16870305
[TBL] [Abstract][Full Text] [Related]
22. Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells.
Heakal Y; Kester M
Mol Cancer Res; 2009 May; 7(5):724-34. PubMed ID: 19435815
[TBL] [Abstract][Full Text] [Related]
23. Insights into the interaction of sortilin with proneurotrophins: a computational approach.
Paiardini A; Caputo V
Neuropeptides; 2008 Apr; 42(2):205-14. PubMed ID: 18191449
[TBL] [Abstract][Full Text] [Related]
24. Neurotensin and the neurotensin receptor-3 in microglial cells.
Martin S; Dicou E; Vincent JP; Mazella J
J Neurosci Res; 2005 Aug; 81(3):322-6. PubMed ID: 15957186
[TBL] [Abstract][Full Text] [Related]
25. Mitogen-activated protein kinase-dependent and -independent routes control shedding of transmembrane growth factors through multiple secretases.
Montero JC; Yuste L; Díaz-Rodríguez E; Esparís-Ogando A; Pandiella A
Biochem J; 2002 Apr; 363(Pt 2):211-21. PubMed ID: 11931648
[TBL] [Abstract][Full Text] [Related]
26. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families.
Nilsson SK; Christensen S; Raarup MK; Ryan RO; Nielsen MS; Olivecrona G
J Biol Chem; 2008 Sep; 283(38):25920-7. PubMed ID: 18603531
[TBL] [Abstract][Full Text] [Related]
27. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor.
Mazella J; Zsürger N; Navarro V; Chabry J; Kaghad M; Caput D; Ferrara P; Vita N; Gully D; Maffrand JP; Vincent JP
J Biol Chem; 1998 Oct; 273(41):26273-6. PubMed ID: 9756851
[TBL] [Abstract][Full Text] [Related]
28. [Neurotensin: reception and intracellular mechanisms of signaling].
Osadchiĭ OE
Usp Fiziol Nauk; 2006; 37(2):52-70. PubMed ID: 16758885
[TBL] [Abstract][Full Text] [Related]
29. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members.
Hermey G; Sjøgaard SS; Petersen CM; Nykjaer A; Gliemann J
Biochem J; 2006 Apr; 395(2):285-93. PubMed ID: 16393139
[TBL] [Abstract][Full Text] [Related]
30. Deciphering Mechanisms of Action of Sortilin/Neurotensin Receptor-3 in the Proliferation Regulation of Colorectal and Other Cancers.
Mazella J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233189
[TBL] [Abstract][Full Text] [Related]
31. A novel form of neurotensin post-translationally modified by arginylation.
Eriste E; Norberg A; Nepomuceno D; Kuei C; Kamme F; Tran DT; Strupat K; Jörnvall H; Liu C; Lovenberg TW; Sillard R
J Biol Chem; 2005 Oct; 280(42):35089-97. PubMed ID: 16087676
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
33. The carboxy-terminal domain of the receptor-associated protein binds to the Vps10p domain of sortilin.
Tauris J; Ellgaard L; Jacobsen C; Nielsen MS; Madsen P; Thøgersen HC; Gliemann J; Petersen CM; Moestrup SK
FEBS Lett; 1998 Jun; 429(1):27-30. PubMed ID: 9657377
[TBL] [Abstract][Full Text] [Related]
34. Blockade of growth hormone receptor shedding by a metalloprotease inhibitor.
Alele J; Jiang J; Goldsmith JF; Yang X; Maheshwari HG; Black RA; Baumann G; Frank SJ
Endocrinology; 1998 Apr; 139(4):1927-35. PubMed ID: 9528979
[TBL] [Abstract][Full Text] [Related]
35. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
Hassan S; Dobner PR; Carraway RE
Regul Pept; 2004 Aug; 120(1-3):155-66. PubMed ID: 15177934
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells.
Carraway RE; Hassan S; Dobner PR
Regul Pept; 2008 Apr; 147(1-3):96-109. PubMed ID: 18313772
[TBL] [Abstract][Full Text] [Related]
37. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
[TBL] [Abstract][Full Text] [Related]
38. The soluble interleukin-6 receptor is generated by shedding.
Müllberg J; Schooltink H; Stoyan T; Günther M; Graeve L; Buse G; Mackiewicz A; Heinrich PC; Rose-John S
Eur J Immunol; 1993 Feb; 23(2):473-80. PubMed ID: 8436181
[TBL] [Abstract][Full Text] [Related]
39. Ca2+ and protein kinase C-dependent mechanisms involved in gastrin-induced Shc/Grb2 complex formation and P44-mitogen-activated protein kinase activation.
Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):383-9. PubMed ID: 9230117
[TBL] [Abstract][Full Text] [Related]
40. Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts.
Siddhanti SR; Hartle JE; Quarles LD
Endocrinology; 1995 Nov; 136(11):4834-41. PubMed ID: 7588214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
